NanoDx
PrivateLast Round
Series C
Jul 1, 2020
Total Funding Raised
$25.95M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
NanoDx operates in Healthcare & Life Sciences and is based in Southborough, Massachusetts. Its latest recorded funding round was a Series C round in July 2020.
NanoDx is a medical device company that develops point-of-care products for the objective diagnosis and management of concussions and other traumatic brain injuries.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Sensors, Biotechnology, Health IoT
Business Model
B2B
Customer Profile
Usage-Based SaaS, Hardware Sales
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
NanoDx Comparables
Compare NanoDx with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Nanopath | 85% | |
| BrainScope | 83% | |
| InfraScan | 80% |
For institutional investors. Book with your work email.
NanoDx Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Jul 1, 2020 | ||||
| VC Round | Apr 10, 2017 | ||||
| Series B | Feb 3, 2016 | ||||
| Series A | Aug 19, 2013 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
NanoDx Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Paulson Investment Company | Series A |
| Provident Healthcare Capital | VC Round, Series B |
| MedScience Ventures | VC Round |
| Shepherd Kaplan Krochuk | Series C |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 26, 2026
Monthly visitors increased 42% MoM, reaching 1.3K.
- Jan 20, 2026
Monthly visitors increased 63% MoM.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- receives_financingSep 18, 2026
Nanodiagnostics Inc. receives $30.1M across six funding rounds, including five early-stage rounds and one late-stage round.
For institutional investors. Book with your work email.
NanoDx Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about NanoDx's valuation, stock price, and market status.
Is NanoDx a public or private company?
NanoDx is a private company.
What is the current stock price of NanoDx?
NanoDx is a private company, so its shares have no public market price. Caplight tracks NanoDx's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is NanoDx worth (valuation)?
Valuation information for NanoDx is not publicly available.
Can I buy NanoDx stock?
NanoDx shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was NanoDx's last funding round?
NanoDx's most recent funding round was Series C on July 1, 2020.
Who are the main investors in NanoDx?
Key investors in NanoDx include Provident Healthcare Capital, Shepherd Kaplan Krochuk.
Will NanoDx IPO soon?
No public IPO plans have been announced for NanoDx.
How can I track NanoDx secondary market activity?
Caplight tracks bids, offers, and trades in NanoDx's shares on secondary markets.